Sculptor Capital’s Rockwell Medical RMTI Stock Holding History

Sculptor Capital’s Portfolio RMTI Stock Details RMTI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-400	Closed	-$275K	–	380
2017 Q1	$275K	Sell	400 -45	-10%	-$29.7K	﹤0.01%	279
2016 Q4	$321K	Buy	+445	New	+$308K	﹤0.01%	288

Other funds holding RMTI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

BKS Advisors Southfield, Michigan $249M AUM 14.37% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Sculptor Capital's RMTI Position: Q2 2017 in Review

Sculptor Capital sold out of Rockwell Medical (RMTI) in Q2 2017, closing a stake of 400 shares — an estimated $275K sold.

Sculptor Capital first reported a position in RMTI in Q4 2016 and held it in 2 quarters. The position peaked at $288K in Q4 2016. 83 funds tracked by Wall St. Rank hold RMTI as of Q2 2017.

Sculptor Capital reported no remaining Rockwell Medical position as of Q2 2017 after selling out during the quarter.
Sculptor Capital sold 400 Rockwell Medical shares in Q2 2017, an estimated $275K.
Sculptor Capital first reported a position in Rockwell Medical in Q4 2016 and held it in 2 quarters.
Sculptor Capital's Rockwell Medical position peaked at $288K in Q4 2016.
83 funds tracked by Wall St. Rank held Rockwell Medical as of Q2 2017.

Based on Sculptor Capital's 13F filing for Q2 2017, filed 8 Aug 2017.